RecruitingNot ApplicableNCT02302482

Predictive Factors and Autonomy Level Change

Predictive Factors of the Autonomy Level Change Related to Memory Disorders


Sponsor

Hospices Civils de Lyon

Enrollment

10,860 participants

Start Date

Nov 1, 2014

Study Type

INTERVENTIONAL

Conditions

Summary

The Alzheimer's disease or related disorders (ADRD) are among the most disabling diseases because of their main features such as cognitive impairment, loss of functional autonomy and behavioural disorders. In absence of current curative treatment, the identification of the predictive risk factors of progression of the disease, evaluated through its main symptoms, represents a major stake of public health. The investigators aimed at developing a database, which includes the patient medical records on a prospective basis, in collaboration with the medical and administrative personal and with the University hospital computer science department. The main objective is to study the predictive factors associated with the change of functional autonomy level, measured every 6 months to 12 months by phone, in a Memory Clinic. The study population would consist in about 1000 patients with ADRD. The length of follow-up of each patient will be 3 years.


Eligibility

Min Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This trial is studying what factors predict changes in independence and daily functioning in people experiencing memory problems, by following them over time at a memory clinic in France. You may be eligible if: you are coming to the memory clinic for the first time; you live at home or in supported housing; and you have memory problems at any stage — mild or more advanced. You may NOT be eligible if: you currently live in a nursing home or care institution; you are under legal guardianship; or you have a hearing or vision problem so severe it would prevent completing the evaluation. Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERThe Lawton Instrumental Activities of Daily Living score (IADL), and the disability assessment of dementia score (DAD-6

Locations(2)

Hôpital Dugoujon

Caluire-et-Cuire, France

Hospices Civils de Lyon - Hôpital des Charpennes

Lyon, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02302482


Related Trials